Skip to Main Content

Author Details

Matthew F Wipperman
Regeneron Pharmaceuticals, Inc.
2012
26
13
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36494054Association of complement pathways with COVID-19 severity and outcomes.Microbes Infect2023
37564104Defining a Unique Gene Expression Profile in Mature and Developing Keloids.JID Innov2023
34723652The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized Patients.Mol Cell Biol2022
35842561Influence of the early-life gut microbiota on the immune responses to an inhaled allergen.Mucosal Immunol2022
36812552A pilot study of the Earable device to measure facial muscle and eye movement tasks among healthy volunteers.PLOS Digit Health2022
36546624Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.N Engl J Med2022
36056118Elevated serum IgA following vaccination against SARS-CoV-2 in a cohort of high-risk first responders.Sci Rep2022
35177035Exploring the value of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children.BMC Infect Dis2022
34636907Anti-SARS-CoV-2 IgA Identifies Asymptomatic Infection in First Responders.J Infect Dis2022
34685683Transcriptomic Biomarkers for Tuberculosis: Validation of <i>NPC2</i> as a Single mRNA Biomarker to Diagnose TB, Predict Disease Progression, and Monitor Treatment Response.Cells2021
33602926Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis.Nat Commun2021
33531385An Antibiotic-Impacted Microbiota Compromises the Development of Colonic Regulatory T Cells and Predisposes to Dysregulated Immune Responses.mBio2021
34703974Developing a Novel Measurement of Sleep in Rheumatoid Arthritis: Study Proposal for Approach and Considerations.Digit Biomark2021
34496013Baseline Severe Acute Respiratory Syndrome Viral Load Is Associated With Coronavirus Disease 2019 Severity and Clinical Outcomes: Post Hoc Analyses of a Phase 2/3 Trial.J Infect Dis2021
32101684IpdE1-IpdE2 Is a Heterotetrameric Acyl Coenzyme A Dehydrogenase That Is Widely Distributed in Steroid-Degrading Bacteria.Biochemistry2020
30803496Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health.Am J Pathol2019
30282828Mucosal-associated invariant and γδ T cell subsets respond to initial Mycobacterium tuberculosis infection.JCI Insight2018
30228238The Microbiome and Tuberculosis: Early Evidence for Cross Talk.mBio2018
30174294Mycobacterial Mutagenesis and Drug Resistance Are Controlled by Phosphorylation- and Cardiolipin-Mediated Inhibition of the RecA Coprotease.Mol Cell2018
28683818Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.Microbiome2017
28883399Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed.Sci Rep2017
26161441Unraveling Cholesterol Catabolism in <i>Mycobacterium tuberculosis</i>: ChsE4-ChsE5 α<sub>2</sub>β<sub>2</sub> Acyl-CoA Dehydrogenase Initiates β-Oxidation of 3-Oxo-cholest-4-en-26-oyl CoA.ACS Infect Dis2015
24611808Pathogen roid rage: cholesterol utilization by Mycobacterium tuberculosis.Crit Rev Biochem Mol Biol2014
23925313Experimental evidence of a cyclopropylcarbinyl conjugative electronic effect.Org Biomol Chem2013
23836861Shrinking the FadE proteome of Mycobacterium tuberculosis: insights into cholesterol metabolism through identification of an α2β2 heterotetrameric acyl coenzyme A dehydrogenase family.J Bacteriol2013
22420624Thermal isomerizations of cis,anti,cis-tricyclo[7.4.0.0(2,8)]tridec-10-ene.J Org Chem2012
  • 1 - 26 of 26

Recommended Authors

Md Zahidul Alam
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2014
Number of shared co-authors 0
Bryan D Bryson
Massachusetts Institute of Technology, USA The Ragon Institute of MGH
Career Start Year 2012
Number of shared co-authors 0
Vaibhav Upadhyay
University of California San Francisco
Career Start Year 2012
Number of shared co-authors 0
Jason Bishai
Yale University
Career Start Year 2010
Number of shared co-authors 0
Rohit Vashisht
University of California san francisco
Career Start Year 2009
Number of shared co-authors 0
Austin D Swafford
Center for Microbiome Innovation, University of California San Diego
Career Start Year 2008
Number of shared co-authors 0
Andrew J Olive
College of Osteopathic Medicine, Michigan State University
Career Start Year 2006
Number of shared co-authors 2
Noah W Palm
Yale University School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Ekaterina Smirnova
Institut de Genetique et de Biologie Moleculaire et Cellulaire
Career Start Year 2005
Number of shared co-authors 0
John Kenneth Baillie
Roslin Institute, University of Edinburgh
Career Start Year 2005
Number of shared co-authors 0
April K Randhawa
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Kyle Bittinger
Children's Hospital of Philadelphia
Career Start Year 2004
Number of shared co-authors 0
Susan V Lynch
University of California san francisco
Career Start Year 2004
Number of shared co-authors 0
Ami S Bhatt
Stanford University
Career Start Year 2003
Number of shared co-authors 0
David J Lynn
South Australian Health and Medical Research Institute
Career Start Year 2002
Number of shared co-authors 0
Peggy S Lai
Harvard Medical School
Career Start Year 2002
Number of shared co-authors 0
Eran Elinav
German Cancer Research Center
Career Start Year 2002
Number of shared co-authors 1
Sarah A Stanley
University of California berkeley
Career Start Year 2001
Number of shared co-authors 2
Antje Blumenthal
Frazer Institute, The University of Queensland
Career Start Year 2001
Number of shared co-authors 0
Victoria J Wright
Imperial College London
Career Start Year 2000
Number of shared co-authors 0
Ephraim L Tsalik
Duke University School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Charles S Dela Cruz
Department of Microbial Pathogenesis Yale University New Haven
Career Start Year 1998
Number of shared co-authors 0
David M Aronoff
Indiana University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Matthias Wittwer
F. Hoffmann-La Roche Ltd.
Career Start Year 1997
Number of shared co-authors 0
Rodrigo Andres Floto
University of Cambridge
Career Start Year 1995
Number of shared co-authors 0
James R Brown
GlaxoSmithKline Pharma R&D, 1250 S. Collegeville Rd, Collegeville
Career Start Year 1994
Number of shared co-authors 0
Mahdad Noursadeghi
University College London
Career Start Year 1992
Number of shared co-authors 1
Ramnik J Xavier
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 0
David R Sherman
University of Washington
Career Start Year 1987
Number of shared co-authors 0
Maria Laura Gennaro
Public Health Research Institute, Rutgers New Jersey Medical School
Career Start Year 1980
Number of shared co-authors 0

Collaborators

Michael S Glickman
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Sara C Hamon
Regeneron Pharmaceuticals
Co-authored papers 5
Jennifer D Hamilton
Regeneron Pharmaceuticals, Inc.
Co-authored papers 4
George D Yancopoulos
Co-authored papers 2
Brook E Heaton
Duke University School of Medicine
Co-authored papers 1
Amiran Dzutsev
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Rafia Bhore
Regeneron Pharmaceuticals
Co-authored papers 1
Henry Evans
Columbia University Vagelos College of Physicians and Surgeons
Co-authored papers 1
Wuxing Yuan
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Rajesh K Soni
Herbert Irving Comprehensive Cancer Center, Columbia University
Co-authored papers 1
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers 1
Astha Nautiyal
Sloan Kettering Institute
Co-authored papers 1
Ronald C Hendrickson
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Giorgio Trinchieri
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Dave van Ditmarsch
Sloan Kettering Institute
Co-authored papers 1
Richa Gupta
Sloan Kettering Institute
Co-authored papers 1
Marc E Rothenberg
Cincinnati Children's Hospital Medical Center
Co-authored papers 1
Vishal Thovarai
Center for Cancer Research
Co-authored papers 1
Oyindamola Adefisayo
Sloan Kettering Institute
Co-authored papers 1
Release 1.2